Corbus Pharmaceuticals (CRBP) PT Lowered to $48 at Oppenheimer
Oppenheimer analyst Jeff Jones lowered ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
